CONTACTAbout UsCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Equal Entertainment LLC.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
We need your help
Your support makes The Advocate's original LGBTQ+ reporting possible. Become a member today to help us continue this work.
Your support makes The Advocate's original LGBTQ+ reporting possible. Become a member today to help us continue this work.
The Food and Drug Administration on Tuesday approved a new, extended-release form of the HIV nucleoside reverse transcriptase inhibitor Zerit (d4T), which will be marketed as Zerit XR by drugmaker Bristol-Myers Squibb. The new formulation can be taken just once a day. Data from clinical trials of the medication show that it is as effective as the standard twice-daily dosing of d4T and that reducing the pill burden may help people with HIV better stick to their anti-HIV drug regimens.
From our Sponsors
Most Popular
Watch Now: Pride Today
Latest Stories
Florida city removes rainbow crosswalk, following Sean Duffy's anti-Pride directive
July 18 2025 5:04 PM
PBS and NPR stations at risk as federal funding is slashed
July 18 2025 1:26 PM
As Trump faces escalating Epstein scandal, Marjorie Taylor Green targets drag queens
July 18 2025 10:35 AM
House Oversight Democrats demand records over RFK Jr.’s HIV program cuts
July 18 2025 3:56 PM
Netflix revives 1998 cold case of a missing lesbian cruise ship passenger
July 18 2025 11:38 AM
Trump sues Murdoch, News Corp, and WSJ over Epstein story
July 18 2025 5:34 PM
Gavin Newsom agrees with anti-trans talking points on yet another MAGA podcast
July 18 2025 3:14 PM
Trump administration kills $18.5 million in funding for diversity, LGBTQ+ support
July 18 2025 1:53 PM
Barack Obama explains why he thinks all men need queer people in their lives
July 18 2025 1:01 PM
Trump was diagnosed with chronic venous insufficiency, but what is it?
July 18 2025 11:26 AM